Centre Hospitalier Universitaire Vaudois

🇨🇭Switzerland

Country: 🇨🇭Switzerland

Ownership: Private

Established: 2008-01-01

Employees: 501

Market Cap: -

Website: http://www.chuv.ch

Clinical Trials

Effect of Platelet Rich Plasma and Keratinocyte Suspensions on Wound Healing

Phase 1

Completed

Conditions: Skin Graft

Interventions: Other: Standard dressings
Biological: Autologous Platelet Rich Plasma
Biological: Keratinocyte suspension

First Posted Date: 2009-03-06

Last Posted Date: 2009-03-06

Lead Sponsor: Centre Hospitalier Universitaire Vaudois

Target Recruit Count: 45

Registration Number: NCT00856934

Locations: 🇨🇭
Centre hospitalier Universitaire Vaudois, Lausanne, Vaud, Switzerland

Study of the Efficacy of Preoperative Cefuroxime Prophylaxis to Prevent Surgical Site Infection in Herniated Disk Surgery

Phase 4

Completed

Conditions: Surgical Wound Infection

Interventions: Drug: cefuroxime
Drug: placebo

First Posted Date: 2007-09-17

Last Posted Date: 2007-09-17

Lead Sponsor: Centre Hospitalier Universitaire Vaudois

Target Recruit Count: 1369

Registration Number: NCT00530400

Locations: 🇨🇭
Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
🇨🇭
Hôpitaux Universitaire de Genève, Geneva, Switzerland

Intravenous Fish Oil in Critically Ill Cardiac Patients

Phase 3

Completed

Conditions: Coronary Artery Disease

Interventions: Drug: Saline
Drug: Fish oil emulsion

First Posted Date: 2007-08-15

Last Posted Date: 2016-02-17

Lead Sponsor: Centre Hospitalier Universitaire Vaudois

Target Recruit Count: 31

Registration Number: NCT00516178

Locations: 🇨🇭
CHUV, Lausanne, VD, Switzerland
🇨🇭
Service of Adult Intensive Care - CHUV, Lausanne, VD, Switzerland

Impact Of Antioxidant Micronutrients On Intensive Care Unit (ICU) Outcome

Phase 3

Terminated

Conditions: Critically Ill Patients
Cardiac Surgery
Trauma
Subarachnoid Hemorrhage

Interventions: Drug: Selenium (Se), Zinc (Zn), Vitamin C, Vitamin B1, Vitamin E
Drug: Placebo

First Posted Date: 2007-08-14

Last Posted Date: 2010-07-30

Lead Sponsor: Centre Hospitalier Universitaire Vaudois

Target Recruit Count: 200

Registration Number: NCT00515736

Locations: 🇨🇭
Dpt of Adult Intensive Care - CHUV, Lausanne, VD, Switzerland

Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer With Liver Metastases or Lung Metastases That Are Potentially Removable by Surgery

Phase 2

Conditions: Colorectal Cancer
Metastatic Cancer

First Posted Date: 2007-08-08

Last Posted Date: 2009-08-07

Lead Sponsor: Centre Hospitalier Universitaire Vaudois

Target Recruit Count: 35

Registration Number: NCT00513266

Locations: 🇨🇭
Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
🇨🇭
Hopital Cantonal Universitaire de Geneve, Geneva, Switzerland
🇨🇭
Kantonspital Aarau, Chur, Switzerland

and more 1 locations

Management of Acute Pain in the Emergency Department

Completed

Conditions: Pain

Interventions: Device: computer-assisted decision support

First Posted Date: 2007-05-08

Last Posted Date: 2009-01-27

Lead Sponsor: Centre Hospitalier Universitaire Vaudois

Target Recruit Count: 631

Registration Number: NCT00470652

Locations: 🇨🇭
Centre Hospitalier Universitaire Vaudois, Lausanne, Vaud, Switzerland

Radiation Therapy, Irinotecan, and Cetuximab in Treating Patients Who Are Undergoing Surgery for Stage III or Stage IV Rectal Cancer

Phase 1

Conditions: Colorectal Cancer

First Posted Date: 2006-10-26

Last Posted Date: 2011-05-25

Lead Sponsor: Centre Hospitalier Universitaire Vaudois

Target Recruit Count: 20

Registration Number: NCT00392470

Locations: 🇨🇭
Kantonsspital Aarau, Aarau, Switzerland
🇨🇭
Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
🇨🇭
Institut Ludwig de Recherche sur le Cancer, Epalinges, Switzerland

Celecoxib in Treating Patients With Head and Neck Cancer That Can Be Removed By Surgery

Phase 1

Conditions: Head and Neck Cancer

First Posted Date: 2006-07-27

Last Posted Date: 2010-12-24

Lead Sponsor: Centre Hospitalier Universitaire Vaudois

Target Recruit Count: 24

Registration Number: NCT00357617

Locations: 🇨🇭
Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland

Immunotherapy of Melanoma Patients

Phase 1

Completed

Conditions: Melanoma

First Posted Date: 2005-06-01

Last Posted Date: 2013-04-24

Lead Sponsor: Centre Hospitalier Universitaire Vaudois

Target Recruit Count: 9

Registration Number: NCT00112216

Locations: 🇨🇭
Ludwig Institute for Cancer Research + Multidisciplinary Oncology Center at the Centre Hospitalier Universitaire Vaudois, Lausanne, Vaud, Switzerland

Immunotherapy of HLA-A2 Positive Stage III/IV Melanoma Patients

Phase 1

Completed

Conditions: Melanoma

Interventions: Biological: group 1
Biological: group 2
Biological: group 3
Biological: group 4

First Posted Date: 2005-06-01

Last Posted Date: 2013-04-22

Lead Sponsor: Centre Hospitalier Universitaire Vaudois

Target Recruit Count: 29

Registration Number: NCT00112229

Locations: 🇨🇭
Ludwig Institute for Cancer Research + Multidisciplinary Oncology Center at the Centre Hospitalier Universitaire Vaudois, Lausanne, Vaud, Switzerland

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy